ALX ONCOLOGY HOLDINGS INC Gain (Loss) on Extinguishment of Debt
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Gain (Loss) on Extinguishment of Debt of -$904.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-06
- ALX ONCOLOGY HOLDINGS INC gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$904.00K.
- ALX ONCOLOGY HOLDINGS INC gain (loss) on extinguishment of debt for fiscal 2020 was -$621.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|
| 2026-06-30 | -$904.00K 10-Q · filed 2026-08-06 | -$904.00K 10-Q · filed 2026-08-06 | |
| 2020-12-31 | -$621.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |